Contrast-induced nephropathy: How it develops, how to prevent it
Michael R. Rudnick, MD
Associate Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia
Aaron Kesselheim, MD
Brigham and Women’s Hospital, Boston
Stanley Goldfarb, MD
Professor of Medicine, University of Pennsylvania School of Medicine, Philadelphia
Address: Michael Rudnick, MD, Presbyterian Medical Center, Medical Office Bldg., Suite 240, 39th and Market Streets, Philadelphia, PA 19104; e-mail email@example.com
Dr. Rudnick has indicated that he has received grant or research support from, serves as a consultant for, and is on the speakers’ bureau of the GE Healthcare corporation.
Dr. Goldfarb has indicated that he is on the speakers’ bureau of the GE Healthcare corporation.
ABSTRACTNo current treatment can reverse or ameliorate contrast-induced nephropathy once it occurs, but prophylaxis is possible. Many preventive measures have failed to show benefits in well-designed, prospective, randomized, double-blinded trials. This review will focus only on the prophylactic strategies that have possible or proven value.
Letters To The Editor
- Michael R. Rudnick, MD